Australian Experiences of Out-of-Pocket Costs and Financial Burden Following a Cancer Diagnosis: A Systematic Review

被引:44
作者
Bygrave, Annie [1 ]
Whittaker, Kate [1 ]
Paul, Christine [2 ,3 ]
Fradgley, Elizabeth A. [2 ,3 ]
Varlow, Megan [1 ]
Aranda, Sanchia [1 ,4 ]
机构
[1] Canc Council Australia, Sydney, NSW 2000, Australia
[2] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia
[3] Hunter Canc Res Alliance, Callaghan, NSW 2308, Australia
[4] Univ Melbourne, Dept Nursing, Parkville, Vic 3010, Australia
关键词
financial toxicity; cancer patient; systematic review; Australia; SURVIVORS; TOXICITY; IMPACT; DISTRESS; INCOME;
D O I
10.3390/ijerph18052422
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
(1) Background: This systematic review was conducted to identify cancer patient experiences, and the impact of out-of-pocket costs and financial burden in Australia. (2) Methods: A systematic review, following the Preferring Reporting Items for Systematic Reviews and Meta-Analyses, was conducted. Cumulative Index of Nursing and Allied Health Literature and PubMed were searched. The primary outcome was financial burden among cancer patients and their families in Australia. The secondary outcome was out-of-pocket costs associated with cancer care and treatment within the population sample, and the impact of financial burden. (3) Results: Nineteen studies were included, covering more than 70,000 Australians affected by cancer. Out-of-pocket costs varied by cancer type and ranged from an average of AUD 977 for breast cancer and lymphoedema patients to AUD 11,077 for prostate cancer patients. Younger aged patients (<= 65 years), Aboriginal and Torres Strait Islander people, people in rural and/or remote areas, households with low income, those who were unemployed and people with private health insurance were at increased risk of experiencing out-of-pocket costs, financial burden or a combination of both. (4) Conclusions: Australians diagnosed with cancer frequently experience financial burden, and the health and financial consequences are significant. Focusing efforts on the costs of care and options about where to have care within the context of informed decisions about cancer care is necessary.
引用
收藏
页码:1 / 24
页数:19
相关论文
共 39 条
  • [1] Australian Institute of Health and Welfare, 2019, CANC SER, V122
  • [2] Australian Institute of Health and Welfare, 2020, CANC DATA AUSTR
  • [3] Australian Institute of Health and Welfare, 2019, HLTH WELF EXP SER, V65
  • [4] CancerCostMod: a model of the healthcare expenditure, patient resource use, and patient co-payment costs for Australian cancer patients
    Bates, Nicole
    Callander, Emily
    Lindsay, Daniel
    Watt, Kerrianne
    [J]. HEALTH ECONOMICS REVIEW, 2018, 8
  • [5] Financial cost of lymphedema borne by women with breast cancer
    Boyages, John
    Xu, Ying
    Kalfa, Senia
    Koelmeyer, Louise
    Parkinson, Bonny
    Mackie, Helen
    Viveros, Hector
    Gollan, Paul
    Taksa, Lucy
    [J]. PSYCHO-ONCOLOGY, 2017, 26 (06) : 849 - 855
  • [6] Breast Cancer Network of Australia, FIN IMP BREAST CANC
  • [7] The patient co-payment and opportunity costs of accessing healthcare for Indigenous Australians with cancer: A whole of population data linkage study
    Callander, Emily
    Bates, Nicole
    Lindsay, Daniel
    Larkins, Sarah
    Preston, Robyn
    Topp, Stephanie M.
    Cunningham, Joan
    Garvey, Gail
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 (06) : 309 - 315
  • [8] Long-term out of pocket expenditure of people with cancer: comparing health service cost and use for indigenous and non-indigenous people with cancer in Australia
    Callander, Emily
    Bates, Nicole
    Lindsay, Daniel
    Larkins, Sarah
    Topp, Stephanie M.
    Cunningham, Joan
    Sabesan, Sabe
    Garvey, Gail
    [J]. INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH, 2019, 18 (1)
  • [9] Carrera PM, MASCC TXB CANC SUPPO
  • [10] The Financial Burden and Distress of Patients with Cancer: Understanding and Stepping-Up Action on the Financial Toxicity of Cancer Treatment
    Carrera, Pricivel M.
    Kantarjian, Hagop M.
    Blinder, Victoria S.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2018, 68 (02) : 153 - 165